Fundraising FoxDevice of Tomorrow Capital
Venture capitalSeed–Growth · 2 people tracked
Find your way into Device of Tomorrow Capital
Sign up to see every warm intro you have to Device of Tomorrow Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Device of Tomorrow Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Device of Tomorrow Capital is an early-stage fund dedicated to medical technology. It seeks visionary founders developing technologies that redefine clinical standards and improve patient outcomes, aiming to invest ahead of transformative technology and commercialization milestones. The firm co-invests alongside leading strategic investors and top-tier venture capital firms, and maintains a diversified portfolio spanning early innovation through commercial growth stages.
Source: firm website, verified Oct 2, 2026.
Team · 2 people
from public directories
What they invest in
from 27 of 29 portfolio companiesMedical Devices ×24Healthtech ×23Biotech ×11AI & Machine Learning ×9Digital Health ×8Hardware ×8Deep Tech ×7Robotics ×2
HQs:United States×13
Who they back
founder profiles across 18 portfolio companiesFounding team size:solo founder×82 founders×53 founders×44+ founders×1
Where their founders studiedfrom 15 founders with education data
Purdue University ×4The Johns Hopkins University ×2
What their founders studiedfrom 17 founders with field-of-study data
Engineering ×11Computer Science ×3Finance & Accounting ×2Life Sciences ×2
Where their founders worked beforefrom 19 founders with career history
Apple ×2
Investments · 29 tracked
founders shown can be your intro pathBy year:2025 · 32022 · 14 dated
GoDaddy provides domain registration, website building, e-commerce, hosting, and business management tools primarily for small business owners, web designers, and domain investors, bundling domain identity services with marketing and commerce capabilities.
Bob Parsons(Founder)inAman Bhutani(Chief Executive Officer)inMark McCaffrey(Chief Financial Officer)inRoger Chen(Chief Operating Officer)Jared Sine(Chief Strategy and Legal Officer)in
Co-investorsAgent CapitalAnsa CapitalBDUCK CapitalBronco VenturesCitta CapitalCrimson Investment Fund+14 more
Andromeda Surgical develops an AI-guided surgical platform that provides GPS-like navigation and autonomous task capabilities to surgeons, starting with endourology procedures.
AI & Machine LearningHealthtechMedical DevicesRoboticsSan Francisco, US
Nick Damiano(Founder)inKartik Tiwari(Founder)inNick Damiano Kartik Tiwari(Founder)Prakul Singh(In-house recruiter)Gaby Falotico(In house recruiter)
Co-investorsAlumni VenturesAttack CapitalBBQ CapitalEarl Grey CapitalLingottoMaiora Rebel Ventures+29 more
Aureka Biotechnologies is a tech-bio startup that combines high-throughput digital biology data with generative AI to discover protein and antibody therapeutics.
AI & Machine LearningBiotechDeep Tech
Co-investorsQiming Venture Partners
CARI Health develops diagnostic solutions for medication monitoring, specifically focused on personalized methadone dosing for opioid use disorder treatment.
BiotechDigital HealthHealthtechMedical DevicesSan Diego, US
Patrik Schmidle(Chief Executive Officer)
BoardGioia Messinger(Director)Charles Patton(Director)
Co-investorsCove FundNuFund Venture Group
Carlsmed develops the aprevo personalized surgery platform for spine fusion procedures, producing patient-specific implants and technology used by spine surgeons.
AI & Machine LearningBiotechHardwareHealthtechMedical DevicesCarlsbad, US
Mike Cordonnier(Co-Founder, President and Chief Executive Officer)inNiall Casey(Co-Founder and Chief Intellectual Property Officer)inShariq Hussain(Chief Technology Officer)inAlexander Arrow(Executive Officer)Sharon Schulzki(Chief Clinical & Market Access Officer)Leo Greenstein(Chief Financial Officer)
Co-investorsAlliance of AngelsB Capital GroupB4 CapitalCove FundPasadena AngelsProta Ventures+2 more
.jpeg){kind=logo}
Centerline Biomedical develops IOPS®, a 510(k)-cleared endovascular navigation technology that provides real-time 3D image guidance for physicians performing catheterization and other endovascular procedures.
BiotechDeep TechHealthtechMedical DevicesCleveland, US
Vikash Goel(Executive Officer)inGulam Khan(Executive Officer, Director)inIndrani Egleston(Executive Officer)inPhil Rackliffe(Executive Officer, Director)inVinod K. Goel(Executive Officer)
BoardMichael Whitman(Director)
Co-investorsJobsOhio VenturesJumpstart Ventures
CranioSense develops IPASS, a non-invasive medical device that measures intracranial pressure using a forehead patch and handheld device, eliminating the need for invasive skull drilling in traumatic brain injury assessment.
HealthtechMedical DevicesBedford, US
Gordon Hirschman(COB & CO-FOUNDER)inRyan Myers(CEO & CO-FOUNDER)inKristian DiMatteo(COO & CO-FOUNDER)in
Co-investorsIllinois VenturesTechstars
EarlyDx develops non-invasive liquid biopsy tests aimed at early cancer detection and precision medicine.
AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices
Jasmine Zhou(Co-founder & Co-CEO)Wing Hung Wong(Co-founder)Peter Li(Co-founder)Michael Power(Co-CEO)Xiaohui Ni(Chief Technology Officer)Jim Liu(Chief Computing Officer)
Co-investorsAlpha Edison
Glean is a urodynamics (UDS) diagnostic system that uses an abdominal sensor to measure bladder function in a natural setting, without catheters or forced bladder filling and emptying.
HardwareHealthtechMedical Devices
Identical Implant develops dental implant technology.
BiotechHardwareMedical Devices
Co-investorsBerkeley Angel NetworkCreative VenturesCrimson Investment FundElmehøj VenturesSCP Ventures, LLCStartX
ImmersiveTouch develops a virtual reality platform that converts patient CT and MRI scan data into interactive 3D simulations of individual patient anatomy for clinicians.
Digital HealthHealthtechMedical DevicesChicago, US
Pat Banerjee(Founder / COO)inFady Charbel(Executive Officer, Director)Ben Burnham(CEO)inP. Pat Banerjee(Executive Officer)
Lazzaro Medical develops a minimally invasive robotic surgery for repairing tracheobronchomalacia (TBM), a degenerative airway disease, using an implantable scaffold system as an alternative to risky open surgery.
BiotechHealthtechMedical DevicesRoboticsBoulder, US
Richard S. Lazzaro, M.D.(Director, Executive Officer, Promoter)inD. Dawn Bitz(Ms. Bitz is the President of the Issuer.)inRobert J. Wiesenberg(Mr. Wiesenberg is the Chief Operating Officer of the Issuer.)inRyan G. Redford(Mr. Redford is the Chief Technology Officer of the Issuer.)Frederick J. Onorato(Mr. Onorato is the Secretary of the Issuer.)inJames R. Polsen(Executive Officer)in
Co-investorsColorado BioScience Association
Leo Cancer Care develops upright radiotherapy and particle therapy solutions that integrate CT imaging with patient positioning systems.
Deep TechHardwareHealthtechMedical Devices
Stephen Towe(Founder)in
Co-investorsCatalio Capital Management, LPSerra VenturesStar51 CapitalYu GalaxyCatalio Capital ManagementMana Ventures
Modality.AI develops an AI-based multimodal assessment platform that uses app-collected data to help diagnose and monitor neurodegenerative diseases such as ALS.
AI & Machine LearningDigital HealthHealthtechMedical Devices
David Suendermann-Oeft(Co-founder & CEO)inDavid Pautler(Co-founder & CTO)in
Co-investorsCARELA Holding GmbHLair East LabsNovalis Biotech
Neurava develops AI-powered wearable devices designed to monitor seizures and cardiorespiratory dysfunction in people with epilepsy, aiming to mitigate the risk of SUDEP (Sudden Unexpected Nocturnal Death in Epilepsy).
AI & Machine LearningHealthtechMedical DevicesBaltimore, US
Vivek Ganesh, PhD(Co-founder)Jay Shah, PhD(Co-founder)Trevor Meyer, PhD(Co-founder)inVivek Ganesh(Executive Officer, Director, Promoter)inJay Shah(Executive Officer, Director, Promoter)in
BoardMona Chadha(Director)in
Co-investorsElevate VenturesFirst Leaf CapitalSugati VenturesSymbiotic Ventures
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.
BiotechDeep TechHealthtechMedical DevicesSomerville, US
MJ Antonini(Founder, CEO)inNicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)in
Co-investorsDolby Family VenturesEmpath VenturesFuture VenturesGreyMatterMana VenturesPioneer+4 more
Paloma Health offers thyroid care products including Daily Thyroid Care, an iodine-free thyroid-support multivitamin blending vitamins, minerals, and botanicals for people managing thyroid conditions such as hypothyroidism and Hashimoto's.
Digital HealthDirect to ConsumerFemTechHealthtechWellness & Fitness
Guillaume ("G") Skalli(Founder)in
Co-investorsAera VCAlpine MeridianCrosscut VenturesFJ LabsKima VenturesRed & Blue Ventures+6 more
Perceptive Medical develops the BaroHawk Vasopressor Management System, an FDA-designated breakthrough device for automated blood pressure control during surgery and intensive care.
HardwareHealthtechMedical Devices
Co-investorsCove FundPasadena Angels
Piezolabs Medical is developing an implantable venous valve platform for patients with severe chronic venous disease, specifically advanced CEAP C5 and C6 stages where venous ulcers recur or fail to heal.
BiotechHealthtechMedical Devices
Pylon Medical is developing a percutaneous, minimally invasive trans-carotid artery access kit, including a closure device, balloon catheter, and reverse-flow aspiration system, for treating carotid obstructions and strokes.
HardwareHealthtechMedical Devices
Sinaptica is a medical device company developing noninvasive brain modulation therapies for Alzheimer's disease, led by scientific experts and experienced medtech executives.
AI & Machine LearningBiotechDigital HealthMedical Devices
Scientific Co-Founder (University of Ferrara)(Scientific Co-Founder)Scientific Co-Founder (Harvard Medical School)(Scientific Co-Founder)
Co-investorsBootstrap Venture PartnersHealthtech CapitalNW AngelSony Ventures CorporationStar51 CapitalTime Zero Capital
Smartlens develops wearable microfluidic devices and AI-powered platforms for remote monitoring and diagnosis of anterior segment eye diseases, particularly glaucoma.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Savas Komban(Founder)in
Co-investors3E Bioventures CapitalAmbit Health VenturesStanford University
Surf Therapeutics develops a non-invasive broad-beam ultrasound platform that stimulates nerves to activate the body's cholinergic anti-inflammatory pathway, aiming to restore immune balance and treat inflammatory and autoimmune disorders without drugs.
Deep TechHealthtechMedical Devices
Co-investorsCapital FactoryGENERAL INCEPTIONRiceberg Ventures PremierStartXTMC Venture FundSOSV+1 more
Telesair develops medical devices focused on patient care, with work spanning strategy, design, engineering, and quality assurance.
AI & Machine LearningHardwareHealthtechMedical DevicesIrvine, US
Don Lin(Co-founder & CEO)inKen Wang(Executive Officer, Director)inDongping Lin(Executive Officer, Director)Matt Margolies(Executive Officer, Director)inJing Zhang(Director)Bo Li(Director)
Co-investorsShangBay Capital LLCHoneywell Ventures
ThruFlo Endovascular is a clinical-stage medical device company developing a dual-limb bifurcation flow diverter to treat complex intracranial aneurysms at arterial branch points, an indication poorly served by existing side-wall flow diverters.
Deep TechHealthtechMedical DevicesIrvine, US
Samuel M. Shaolian(Co-founder & CEO)George Teitelbaum(Co-founder; Scientific Advisory Board)Peter Qi(Director)
Vonova develops the Cerebro Platform, a minimally invasive neurovascular system that uses the body's venous system to access the brain, guided by real-time imaging to deliver diagnostic and therapeutic treatments without drilling through the skull.
Deep TechHealthtechMedical Devices
José Morales(Dr.)
Co-investorsXEIA Venture PartnersSmartGateVC
Watershed is a biotech company developing sustained-release, self-clearing drug therapies delivered directly into the bladder, initially targeting bladder cancer with plans to expand into other disease states.
BiotechHealthtech
Wearlinq develops the eWave, a wireless, FDA-cleared 6-lead continuous ECG cardiac monitor with a patient smartphone app and the LiveLinq platform for clinicians to review ECG waveforms and reports.
Digital HealthHardwareMedical DevicesSan Francisco, US
Michael Torres(Executive Officer)inChris Daniel(Executive Officer)inYuxin Liu(Executive Officer, Director)Konrad Morzkowski(Executive Officer, Director)
BoardKrish W. Ramadurai(Director)inJoseph Knight(Director)
Co-investorsAIX VenturesAju IB InvestmentAlumni VenturesAmino CapitalCeltic House Asia PartnersHealthtech Capital+7 more
-2.png)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Device of Tomorrow Capital portfolio company
Exits · 1
1 IPOsGoDaddyNYSE: GDDY
Portfolio news
latest coverage across their companiesGoDaddy · domainnamewire.com · Sep 24, 2026
Surf Therapeutics · finsmes.com · Apr 13, 2026
Wearlinq · finsmes.com · Dec 18, 2025
CranioSense · finance.yahoo.com · Dec 17, 2025
NeuroBionics · neurobionics.io · Dec 16, 2025
Smartlens · finsmes.com · Oct 14, 2025
Frequently asked questions
- How many investments has Device of Tomorrow Capital made?
- Device of Tomorrow Capital has 29 tracked investments, 1 of which have exited, including 3 dated in the last 24 months.
- What stage does Device of Tomorrow Capital invest at?
- Device of Tomorrow Capital invests at the Seed, Series A, Growth stages.
- What sectors does Device of Tomorrow Capital focus on?
- Device of Tomorrow Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- Who does Device of Tomorrow Capital co-invest with?
- Device of Tomorrow Capital most often shares deals with StartX, Cove Fund, Healthtech Capital, among 96 tracked co-investors.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.